Novartis: H1N1 vaccine provides strong immune response

09/3/2009 | Reuters

Novartis' H1N1 flu vaccine Celtura was well-tolerated by 100 volunteers who received at least one dose, a company official said. Additional trials are under way involving more than 6,000 adults and children.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA